SHL Telemedicine's SmartHeart® Technology to Take Center Stage at Upcoming VPM 2023 Conference

TEL AVIV, Israel & ZURICH & NEW YORK, September 11, 2023--SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, is pleased to announce that initial results from trials conducted by the Mayo Clinic (as part of a previously announced collaboration) and by Imperial College London will be featured in two upcoming presentations at the Imperial Vulnerable Plaque and Patient Meeting 2023 (VPM). Both tria

Related Keywords

London ,City Of ,United Kingdom ,Erez Nachtomy ,Naseer Alshahrani ,Joerg Hermann ,Ramzi Khamis ,Swiss Exchange ,Nasdaq Stock Exchange ,Imperial College London ,Acute Coronary Syndrome ,Mayo Clinic ,Major Adverse Cardiovascular Events ,Vulnerable Plaque ,Patient Meeting ,Pm ,Heart Attack ,Hl ,Telemedicine Solutions ,Cg ,Initial Results ,Elemedicine ,